These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37369168)

  • 21. A fluvoxamine-related fatality: Case report with postmortem concentrations.
    Otter J; McIntyre IM; Morhaime J; Cantrell L
    Forensic Sci Int; 2019 Jul; 300():e31-e33. PubMed ID: 30871740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.
    Lobo ED; Bergstrom RF; Reddy S; Quinlan T; Chappell J; Hong Q; Ring B; Knadler MP
    Clin Pharmacokinet; 2008; 47(3):191-202. PubMed ID: 18307373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man.
    Becquemont L; Le Bot MA; Riche C; Funck-Brentano C; Jaillon P; Beaune P
    Pharmacogenetics; 1998 Apr; 8(2):101-8. PubMed ID: 10022747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U; Gram LF; Vistisen K; Loft S; Poulsen HE; Brøsen K
    Eur J Clin Pharmacol; 1996; 51(1):73-8. PubMed ID: 8880055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmortem diffusion of drugs from the bladder into femoral venous blood.
    Moriya F; Hashimoto Y
    Forensic Sci Int; 2001 Dec; 123(2-3):248-53. PubMed ID: 11728758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between fluvoxamine and cotinine or caffeine.
    Yoshimura R; Ueda N; Nakamura J; Eto S; Matsushita M
    Neuropsychobiology; 2002; 45(1):32-5. PubMed ID: 11803239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
    Granfors MT; Backman JT; Neuvonen M; Ahonen J; Neuvonen PJ
    Clin Pharmacol Ther; 2004 Apr; 75(4):331-41. PubMed ID: 15060511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically significant pharmacokinetic interactions between dietary caffeine and medications.
    Carrillo JA; Benitez J
    Clin Pharmacokinet; 2000 Aug; 39(2):127-53. PubMed ID: 10976659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accidental death of elderly persons under the influence of chlorpheniramine.
    Suzuki H; Shigeta A; Fukunaga T
    Leg Med (Tokyo); 2013 Sep; 15(5):253-5. PubMed ID: 23747192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study.
    Wójcikowski J; Daniel WA
    Pharmacol Rep; 2009; 61(5):851-8. PubMed ID: 19904008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat.
    Kot M; Daniel WA
    Pharmacol Rep; 2008; 60(6):789-97. PubMed ID: 19211970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.
    Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Rocci ML; Kulawy RW; Beck DJ; Bertino JS
    Clin Pharmacol Ther; 1998 Sep; 64(3):257-68. PubMed ID: 9757149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An autopsy case of drowning under the influence of multiple psychotropic drugs.
    Arch Med Sadowej Kryminol; 2019; 69(4):222-227. PubMed ID: 32564578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects.
    Darwish M; Kirby M; Robertson P; Hellriegel ET
    Clin Pharmacokinet; 2008; 47(1):61-74. PubMed ID: 18076219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro.
    Wang JS; Backman JT; Wen X; Taavitsainen P; Neuvonen PJ; Kivistö KT
    Pharmacol Toxicol; 1999 Nov; 85(5):201-5. PubMed ID: 10608481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service.
    Jerling M; Lindström L; Bondesson U; Bertilsson L
    Ther Drug Monit; 1994 Aug; 16(4):368-74. PubMed ID: 7974626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction.
    Abraham K; Geusau A; Tosun Y; Helge H; Bauer S; Brockmöller J
    Clin Pharmacol Ther; 2002 Aug; 72(2):163-74. PubMed ID: 12189363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The major fluvoxamine metabolite in urine is formed by CYP2D6.
    Spigset O; Axelsson S; Norström A; Hägg S; Dahlqvist R
    Eur J Clin Pharmacol; 2001 Nov; 57(9):653-8. PubMed ID: 11791895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autopsy case of death by combined use of benzodiazepines and diphenidine.
    Kinoshita H; Tanaka N; Takakura A; Abe H; Kumihashi M; Shibayama T; Jamal M; Ito A; Tsutsui K; Kimura S; Iwase H; Ameno K
    Soud Lek; 2017; 62(4):40-43. PubMed ID: 29227117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.